ATE88633T1 - Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose. - Google Patents

Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.

Info

Publication number: ATE88633T1
Authority: AT; Austria
Prior art keywords: calcium citrate; citrate malate; osteoporosis; treatment; malate
Prior art date: 1987-08-28

Application number

AT88201733T

Other languages

English (en)

Inventor

Barbara Ann Kochanowski

Original Assignee

Norwich Eaton Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-08-28

Filing date

1988-08-15

Publication date

1993-05-15

1988-08-15 Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma

1993-05-15 Application granted granted Critical

1993-05-15 Publication of ATE88633T1 publication Critical patent/ATE88633T1/de

Links

229940092124 calcium citrate malate Drugs 0.000 title abstract 5
MPCMQXRREZMSPJ-UHFFFAOYSA-L calcium;2-hydroxybutanedioate;2-hydroxypropane-1,2,3-tricarboxylic acid;pentahydrate Chemical compound O.O.O.O.O.[Ca+2].[O-]C(=O)C(O)CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O MPCMQXRREZMSPJ-UHFFFAOYSA-L 0.000 title abstract 5
208000001132 Osteoporosis Diseases 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
210000000988 bone and bone Anatomy 0.000 abstract 1
159000000007 calcium salts Chemical class 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
229940049920 malate Drugs 0.000 abstract 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000006186 oral dosage form Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Inorganic Chemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Polymers & Plastics (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Endocrinology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Non-Alcoholic Beverages (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

AT88201733T 1987-08-28 1988-08-15 Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose. ATE88633T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9100687A	1987-08-28	1987-08-28
EP88201733A EP0304986B1 (de)	1987-08-28	1988-08-15	Verwendung von bestimmten Calcium-Citrate-Malaten zur Herstellung einer pharmazeutischen Zubereitung für die Behandlung von Osteoporose.

Publications (1)

Publication Number	Publication Date
ATE88633T1 true ATE88633T1 (de)	1993-05-15

Family

ID=22225323

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88201733T ATE88633T1 (de)	1987-08-28	1988-08-15	Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.

Country Status (9)

Country	Link
EP (1)	EP0304986B1 (de)
JP (1)	JP2738541B2 (de)
KR (1)	KR970009582B1 (de)
AT (1)	ATE88633T1 (de)
CA (1)	CA1329774C (de)
DE (1)	DE3880587T2 (de)
HK (1)	HK94096A (de)
IE (1)	IE61451B1 (de)
PH (1)	PH25585A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5108761A (en) *	1990-10-01	1992-04-28	The Procter & Gamble Company	Method of preventing tooth enamel erosion utilizing an acidic beverage containing calcium
EP0557413A1 (de) *	1990-10-31	1993-09-01	The Procter & Gamble Company	Mit kalzium angereicherte sossen
US5389387A (en) *	1991-12-26	1995-02-14	The Procter & Gamble Company	Storage stable calcium-supplemented beverage concentrates
EP0622992B1 (de) *	1991-12-26	1998-10-14	The Procter & Gamble Company	Lagerstabile getränkskonzentrate mit kalziumzusatz
AU4597293A (en) *	1992-06-30	1994-01-24	Procter & Gamble Company, The	Effervescent calcium supplements
CA2146632C (en) *	1992-10-21	1999-02-23	Alice Lyles Burkes	Sweetener containing a concentrated bioavailable calcium source
CA2146631C (en) *	1992-10-21	1999-07-20	Alice Lyles Burkes	Storage stable calcium-supplemented beverage premix concentrates and syrups
ES2152263T3 (es) *	1992-10-21	2001-02-01	Procter & Gamble	Fuente de calcio biodisponible concentrado.
IT1256300B (it) *	1992-11-05	1995-11-29	Dompe Farmaceutici Spa	Uso di acidi aril-, eteroaril- e alchiltartronici come agenti terapeutici
US6811800B2 (en)	1998-09-29	2004-11-02	The Procter & Gamble Co.	Calcium fortified beverages
JP2002525091A (ja) *	1998-09-29	2002-08-13	ザプロクターアンドギャンブルカンパニー	栄養性カルシウム源が補給された低酸性飲料
US8889195B2 (en) *	2006-08-17	2014-11-18	The Procter & Gamble Company	Compositions comprising calcium citrate malate and methods for making the same
TR200908237A2 (tr)	2009-11-02	2011-05-23	Bi̇lgi̇ç Mahmut	Kalsiyum ve D vitamini içeren farmasötik bileşimler.
EP2685973A1 (de) *	2011-03-16	2014-01-22	The Charlotte-Mecklenburg Hospital Authority D/B/A	Zusammensetzungen und verfahren zur behandlung von muskelskeletterkrankungen und erkrankungen unter verwendung von ionen-citrat-analoga-komplexen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5697248A (en) *	1979-12-28	1981-08-05	Tanaka Shiro	Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) *	1986-07-09	1988-01-15	Sandoz Lab	Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) *	1987-07-02	1988-11-22	The Procter & Gamble Company	Calcium-iron mineral supplements

1988
- 1988-08-15 EP EP88201733A patent/EP0304986B1/de not_active Expired - Lifetime
- 1988-08-15 DE DE8888201733T patent/DE3880587T2/de not_active Expired - Lifetime
- 1988-08-15 AT AT88201733T patent/ATE88633T1/de not_active IP Right Cessation
- 1988-08-25 CA CA000575678A patent/CA1329774C/en not_active Expired - Lifetime
- 1988-08-26 KR KR88010858A patent/KR970009582B1/ko not_active Expired - Lifetime
- 1988-08-26 PH PH37460A patent/PH25585A/en unknown
- 1988-08-26 IE IE260988A patent/IE61451B1/en not_active IP Right Cessation
- 1988-08-27 JP JP63213488A patent/JP2738541B2/ja not_active Expired - Lifetime
1996
- 1996-05-30 HK HK94096A patent/HK94096A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0304986A2 (de)	1989-03-01
KR890003390A (ko)	1989-04-14
IE61451B1 (en)	1994-11-02
JP2738541B2 (ja)	1998-04-08
HK94096A (en)	1996-06-07
KR970009582B1 (en)	1997-06-14
EP0304986A3 (en)	1990-03-07
CA1329774C (en)	1994-05-24
JPH01151515A (ja)	1989-06-14
DE3880587D1 (de)	1993-06-03
PH25585A (en)	1991-08-08
DE3880587T2 (de)	1993-09-23
EP0304986B1 (de)	1993-04-28
IE882609L (en)	1989-02-28

Legal Events

Date	Code	Title	Description
1993-12-15	UEP	Publication of translation of european patent specification
2008-11-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE204178T1 (de)	2001-09-15	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69016755D1 (de)	1995-03-23	Pharmazeutische Zubereitung mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen.
ATE88633T1 (de)	1993-05-15	Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
ATE69378T1 (de)	1991-11-15	Pharmazeutische zusammensetzungen.
ATE130762T1 (de)	1995-12-15	Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
DE69230112D1 (de)	1999-11-11	Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
ATE71629T1 (de)	1992-02-15	Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
RU98111594A (ru)	2000-05-20	Фармацевтические композиции, включающие флурбипрофен
DE69634357D1 (de)	2005-03-24	Formulierungen mit dem wasserfreien mononatriumsalz von alendronat und deren verwendung zur behandlung von knochenkrankheiten
ATE133859T1 (de)	1996-02-15	Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
ATE82120T1 (de)	1992-11-15	Kalziumzusaetze.
DE3685853D1 (de)	1992-08-06	Mittel zur behandlung von knochenkrankheiten.
DE69420776D1 (de)	1999-10-28	Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
ATE126061T1 (de)	1995-08-15	Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
DE58903659D1 (de)	1993-04-08	Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
HU896916D0 (en)	1991-08-28	Process for producing medical preparation for treating toxoplasmosis
DE3879489D1 (de)	1993-04-22	Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
HUT60431A (en)	1992-09-28	Process for producing pharmaceutical compositions comprising naphthoquinone derivative and suitable for treating cryptosporidiosis
DE68901018D1 (de)	1992-04-23	Arzneimittel zur regulierung der hormonellen sekretionen und zur behandlung der weiblichen sterilitaet.
Britten	1969	Prophylaxis in hemophilia
ANDREWS	1971	THE EFFECTS OF CALCITONIN DURING RAPID PALATAL EXPANSION IN DOGS
DE3776662D1 (de)	1992-03-19	Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
DE3887005D1 (de)	1994-02-24	Mittel zur Behandlung von Nierenbeschwerden.